Black Diamond Therapeutics, Inc. (BDTX)
2.825
+0.16
(+5.81%)
USD |
NASDAQ |
Dec 11, 15:34
Black Diamond Therapeutics Shareholders Equity (Quarterly): 126.15M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 79.28B |
| Puma Biotechnology, Inc. | 115.27M |
| Cidara Therapeutics, Inc. | 422.39M |
| Oric Pharmaceuticals, Inc. | 406.92M |
| Acumen Pharmaceuticals, Inc. | 93.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 157.73M |
| Total Liabilities (Quarterly) | 31.58M |
| Debt to Equity Ratio | 0.1559 |
| Current Ratio | 8.941 |
| Net Debt Paydown Yield | 0.38% |